HiFiBiO

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.hifibio.com

Last Round

Series D

Jun 14, 2021

Total Funding Raised

$179.5M

Company Overview

HiFiBiO Therapeutics is a biotechnology company that develops a single-cell analytics platform aimed at harnessing the human immune system to fight cancer and autoimmune disorders through innovative biotherapeutics.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Infrastructure

Keywords

Drug Intelligence Science (DIS®) platformAI-driven therapeutic antibody discoveryHigh-throughput single-cell B-cell screeningSingle-cell drug discovery platformPredictive biomarker discovery from patient samplesImmunotherapy for cancer and autoimmune diseasesNovel drug target identificationClinical-stage immunotherapy companyBiopharma drug discovery partnershipAntibody therapy co-developmentTNFR2 agonist immunotherapyTranslational discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HiFiBiO Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

HiFiBiO Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series D	Jun 14, 2021
Series C	Aug 28, 2019
Series B	May 16, 2018
Series A	Jan 27, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Fred Dom

Chief Executive Officer

Executive Team

Helmuth van Es

Advisor To The CEO

Executive Team

HiFiBiO Investors

Notable investors and investment history

Investor	Rounds
Legend Star	Series D
Nest Bio Ventures	Series B, Series A
B Capital Group	Series D
IDG Capital	Series C
LYFE Capital	Series C, Series B
Hong Kong Science and Technology Park	Series D
Sequoia Capital	Series C

View all Investors

HiFiBiO Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

HiFiBiO Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HiFiBiO's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range42

Year Founded2013

Last FundingJun 14, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.